Adrienne
Rivlin

Director, Head of Healthcare and Life Sciences Strategy, UK

KPMG in the UK

Adrienne has over fifteen years consulting experience in both the public and private sector. She specialises in Healthcare and Life Sciences strategy advisory with a particular focus on pharmaceuticals, biotech, medical devices, diagnostics, medtech, and OTC. Her functional specialties include patient pathways redesign, market analysis and entry strategies, strategic options assessments, and commercial due diligence.

Adrienne has previously held a number of diverse roles in academia in the Medical and Social Sciences, public policy development and consulting. She is the author of numerous articles in leading scholarly journals, and is a keen and regular contributor to industry debates producing papers and comments on issues impacting the Life Sciences sector.

Areas of expertise

Business strategyEnterpriseHealthcareLife SciencesMergers and acquisitionsTransactions